Anti-kit antibodies
AssigneeKolltan Pharmaceuticals, Inc.
InventorsYaron Hadari, Susanne Radke, Joseph Schlessinger, Yoshihisa Suzuki
Life of this patent
Estimating the term…
Loading patent…
AssigneeKolltan Pharmaceuticals, Inc.
InventorsYaron Hadari, Susanne Radke, Joseph Schlessinger, Yoshihisa Suzuki
Estimating the term…
Provided herein, in one aspect, are antibodies that immunospecifically bind to a human KIT antigen comprising the fourth and/or fifth extracellular Ig-like domains (that is, D4 and/or D5 domains), polynucleotides comprising nucleotide sequences encoding such antibodies, and expression vectors and host cells for producing such antibodies. The antibodies can inhibit KIT activity, such as ligand-induced receptor phosphorylation. Also provided herein are kits and pharmaceutical compositions comprising antibodies that specifically bind to a KIT antigen, as well as methods of treating or managing a KIT-mediated disorder or disease and methods of diagnosing a KIT-mediated disorder or disease using the antibodies described herein.
An isolated antibody or an antigen-binding fragment thereof, which immunospecifically binds to a D4/D5 region of human KIT (SEQ ID NO:
Dependencies are inferred from the claim text.